Our results indicated that the mRNA expression of PRMT1 and RPL29 was significantly increased in CML CD34+ cells relative to CD34− cells (Figure 4E). The gene discussed is RPL29; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.